OptMyCare offers a cloud-based SaaS platform that combines precision analytics with actionable risk stratification solutions across multiple chronic conditions. The company's clinically engineered algorithms analyze data from 55 chronic clinical diagnoses, associated procedures, and claims costs to facilitate rapid and accurate risk identification. OptMyCare's technology delivers precise, actionable insights, empowering healthcare providers to make informed decisions and prioritize interventions based on comprehensive risk assessments, including quality care gap identification.
Founded in 2019, OptMyCare's advanced analytics engine not only predicts but also stratifies a member's risk across all healthcare conditions. This holistic approach ensures that every aspect of a patient's health is analyzed, providing a complete picture of potential risks and cost drivers. The company's predictive and prescriptive solutions actively help risk bearers improve workflow, lowering the time and cost involved in the process.
In May 2024, OptMyCare raised USD 3 million in Series A funding led by LiveOak Ventures, bringing its total funding to USD 4.5 million. The funds will be used to accelerate customer acquisition plans, refine the technology, onboard key management personnel, and add experienced healthcare and technology leaders.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.